Cargando…

Interferon Kappa Is Up-Regulated in Psoriasis and It Up-Regulates Psoriasis-Associated Cytokines in vivo

PURPOSE: There is increased type I interferon signature in psoriasis patients. Interferon-kappa (IFN-κ) is a member of type I interferon family that is constitutively expressed by keratinocytes. In this study, we investigate whether IFN-κ is involved in psoriasis etiology. PATIENTS AND METHODS: Twen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yuanyuan, Song, Yueqi, Zhu, Leqing, Wang, Xiao, Yang, Bin, Lu, Ping, Chen, Quan, Bin, Lianghua, Deng, Liehua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890215/ https://www.ncbi.nlm.nih.gov/pubmed/31819584 http://dx.doi.org/10.2147/CCID.S218243

Ejemplares similares

Interferon Kappa Is Important for Keratinocyte Host Defense against Herpes Simplex Virus-1
por: Li, Yuanyuan, et al.
Publicado: (2020)

Up-regulation of Interferon-inducible protein 16 contributes to psoriasis by modulating chemokine production in keratinocytes
por: Cao, Tianyu, et al.
Publicado: (2016)

Forkhead Box C1 Regulates Human Primary Keratinocyte Terminal Differentiation
por: Bin, Lianghua, et al.
Publicado: (2016)

Correction: Forkhead Box C1 Regulates Human Primary Keratinocyte Terminal Differentiation
por: Bin, Lianghua, et al.
Publicado: (2018)

Author Correction: Up-regulation of Interferon-inducible protein 16 contributes to psoriasis by modulating chemokine production in keratinocytes
por: Cao, Tianyu, et al.
Publicado: (2020)

Expression of Nuclear Factor Kappa B and Survivin in Psoriasis
por: Gunduz, Kamer, et al.
Publicado: (2012)

Multiple drugs: COVID-19, psoriasis vulgaris flare-up and exacerbation of psoriasis vulgaris led to erythrodermic psoriasis: 2 case reports
Publicado: (2022)

Psoriasis and Hepatitis C: Improvement with Interferon
por: Habte-Gabr, Eyassu, et al.
Publicado: (2011)

miRNAs Flowing Up and Down: The Concerto of Psoriasis
por: Xiuli, Yang, et al.
Publicado: (2021)

Nivolumab/tozinameran: Flare-up of psoriasis: case report
Publicado: (2021)

Interferons as cytokines regulating leukocyte functions in vivo
por: Virelizier, J.-L.
Publicado: (1985)

Evaluation of cytokine gene expression in psoriasis
por: Divyapriya, Dakshinamurthy, et al.
Publicado: (2021)

The Role of IL-17 Cytokines in Psoriasis
por: Mosca, Megan, et al.
Publicado: (2021)

The effect of secukinumab treatment for psoriasis on serum cytokines and correlation with disease severity
por: Wu, Lan‐Tu‐Ya, et al.
Publicado: (2023)

Regulation of IL-22BP in psoriasis
por: Voglis, Stefanos, et al.
Publicado: (2018)

Genetic Variations of Cytokines and Cytokine Receptors in Psoriasis Patients from China
por: Li, Xiao-Lan, et al.
Publicado: (2014)

Cytokine Profiles and the Relationship of Disease Severity in Patients with Psoriasis
por: Wang, Qingqing, et al.
Publicado: (2022)

Type I Interferon: Potential Therapeutic Target for Psoriasis?
por: Yao, Yihong, et al.
Publicado: (2008)

Role of interferon regulatory factor-mediated signaling in psoriasis
por: Wang, Wen-Ming, et al.
Publicado: (2021)

Tissue and Serum Inflammatory Cytokine Levels in Korean Psoriasis Patients: A Comparison between Plaque and Guttate Psoriasis
por: Roh, Nam Kyung, et al.
Publicado: (2015)

Human CLA(+) Memory T Cell and Cytokines in Psoriasis
por: de Jesús-Gil, Carmen, et al.
Publicado: (2021)

Emotions, Alexithymia, and Emotion Regulation in Patients With Psoriasis
por: Panasiti, Maria Serena, et al.
Publicado: (2020)

Mast cells as important regulators in the development of psoriasis
por: Zhou, Xu-Yue, et al.
Publicado: (2022)

Transcriptional regulation on effector T cells in the pathogenesis of psoriasis
por: Qu, Yuying, et al.
Publicado: (2023)

Regulation of psoriasis, colitis, and the intestinal microbiota by clusterin
por: Jun, Yu Kyung, et al.
Publicado: (2023)

Evidence and Suggested Therapeutic Approach in Psoriasis of Difficult-to-treat Areas: Palmoplantar Psoriasis, Nail Psoriasis, Scalp Psoriasis, and Intertriginous Psoriasis
por: Sarma, Nilendu
Publicado: (2017)

IL‐35 recombinant protein reverses inflammatory bowel disease and psoriasis through regulation of inflammatory cytokines and immune cells
por: Wang, Yuan, et al.
Publicado: (2017)

Extensive psoriasis induced by pegylated interferon: a case report
por: Citro, Vincenzo, et al.
Publicado: (2007)

Correction: Type I Interferon: Potential Therapeutic Target for Psoriasis?
por: Yao, Yihong, et al.
Publicado: (2009)

The Role of Plasmacytoid Dendritic Cells and Interferon-Alpha in the Immunopathogenesis of Psoriasis
por: Denadai, Rafael
Publicado: (2013)

Heterogeneity of Inflammatory and Cytokine Networks in Chronic Plaque Psoriasis
por: Swindell, William R., et al.
Publicado: (2012)

Sleep Loss and Cytokines Levels in an Experimental Model of Psoriasis
por: Hirotsu, Camila, et al.
Publicado: (2012)

Profiling Serum Cytokines and Anticytokine Antibodies in Psoriasis Patients
por: Hong, Dan, et al.
Publicado: (2022)

Serum LL‐37 and inflammatory cytokines levels in psoriasis
por: Lao, Juanfeng, et al.
Publicado: (2023)

Cancer risk in hospitalised psoriasis patients: a follow-up study in Sweden
por: Ji, J, et al.
Publicado: (2009)

New-Onset Guttate Psoriasis: A Long-Term Follow-Up Study
por: Galili, Eran, et al.
Publicado: (2023)

Psoriasis Flare-Up in a Patient Treated With Docetaxel for Metastatic Prostate Cancer
por: Kurian, Matthew, et al.
Publicado: (2023)

Shikonin combined with methotrexate regulate macrophage polarization to treat psoriasis
por: Tao, Tingjun, et al.
Publicado: (2022)

Homocysteine and psoriasis
por: Lin, Xiran, et al.
Publicado: (2019)

Down-regulated GATA-1 up-regulates interferon regulatory factor 3 in lung adenocarcinoma
por: Wang, Lu-Lu, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vliqi799fv7vpujenldqusertj